Latest News
Instem to Showcase Enhanced Provantis Pathology Solution at Upcoming STP Symposium
Powerful study management updates provide cutting-edge digital pathology capabilities.
PHILADELPHIA, PA – (BUSINESS WIRE) – June 13, 2024 – Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it will be showcasing its enhanced Provantis® Pathology Solution at this year’s Society of Toxicologic Pathology (STP) Symposium June 16-19, in Baltimore, MD.
Instem Enables Clients to Leverage ICH S1B Weight of Evidence Guideline
January 25, 2024 - Advance™ technology-enabled solution enables R&D organizations to cut study timelines, deliver cost savings and reduce animal experimentation.
Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact
November 27, 2023 - Healthcare investment specialist ARCHIMED has the expertise, experience, enthusiasm and financial strength to fully back Instem’s ambitions.
Instem Announces New Software Solution to Support Updated Nitrosamines Guidance
September 28, 2023 - New Software Module Introduced to Support the Latest Regulatory-approved Carcinogenic Potency Categorization Approach (CPCA)
Instem Announces Transfer of ToxHub Platform and launch of Centrus®
May 15, 2023 - New powerful technology and data sharing suite provides a range of translational science solutions
Events
Presenting at the Phuse Data Transparency Autumn Event 2024
September 17 - 19, 2024
Virtual
Presentation
'Writing Better CSRs to Facilitate Anonymisation for Clinical Data Publication'
Cathal Gallagher, Clinical Trial Transparency Solution Owner, Instem
Laura Dodd, Clinical Trial Transparency Director, Instem
Solution Areas: Clinical Trial Transparency
Presenting at the 14th Annual Global Summit Regulatory Science Symposium
September 18 - 19, 2024
Little Rock, Arkansas
Presentation
'AI applications in Predictive Toxicology Supporting Drug Safety Assessments'
Kevin Cross, PhD, Head of Science, Instem
Solution Areas: In Silico Solutions